Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR
Open Access
- 8 April 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 22 (14) , 2905-2913
Abstract
Mutations in GFPT1 underlie a congenital myasthenic syndrome (CMS) characterized by a limb-girdle pattern of muscle weakness. Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is a key rate-limiting enzyme in the hexosamine biosynthetic pathway providing building blocks for the glycosylation of proteins and lipids. It is expressed ubiquitously and it is not readily apparent why mutations in this gene should cause a syndrome with symptoms restricted to muscle and, in particular, to the neuromuscular junction. Data from a muscle biopsy obtained from a patient with GFPT1 mutations indicated that there were reduced endplate acetylcholine receptors. We, therefore, further investigated the relationship between identified mutations in GFPT1 and expression of the muscle acetylcholine receptor. Cultured myotubes derived from two patients with GFPT1 mutations showed a significant reduction in cell-surface AChR expression (Pt1 P < 0.0001; Pt2 P = 0.0097). Inhibition of GFPT1 enzymatic activity or siRNA silencing of GFPT1 expression both resulted in reduced AChR cell-surface expression. Western blot and gene-silencing experiments indicate this is due to reduced steady-state levels of AChR α, δ, ɛ, but not β subunits rather than altered transcription of AChR-subunit RNA. Uridine diphospho-N-acetylglucosamine, a product of the hexosamine synthetic pathway, acts as a substrate at an early stage in the N-linked glycosylation pathway. Similarity between CMS due to GFPT1 mutations and CMS due to DPAGT1 mutations would suggest that reduced endplate AChR due to defective N-linked glycosylation is a primary disease mechanism in this disorder.Keywords
This publication has 33 references indexed in Scilit:
- Mutations in DPAGT1 Cause a Limb-Girdle Congenital Myasthenic Syndrome with Tubular AggregatesThe American Journal of Human Genetics, 2012
- Congenital Myasthenic Syndrome: A Brief ReviewPediatric Neurology, 2012
- Current status of the congenital myasthenic syndromesNeuromuscular Disorders, 2012
- Hexosamine Biosynthetic Pathway Mutations Cause Neuromuscular Transmission DefectThe American Journal of Human Genetics, 2011
- Molecular architecture of the neuromuscular junctionMuscle & Nerve, 2005
- N-Linked Glycosylation Is Required for Nicotinic Receptor Assembly but Not for Subunit Associations with CalnexinJournal of Biological Chemistry, 2005
- Glucosamine-6-phosphate synthase—the multi-facets enzymeBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2002
- Role for a synapse-specific carbohydrate in agrin-induced clustering of acetylcholine receptorsNeuron, 1995
- Altered patterns ofN-linked glycosylation of theTorpedo acetylcholine receptor expressed inXenopus oocytesThe Journal of Membrane Biology, 1990
- The human medulloblastoma cell line TE671 expresses a muscle‐like acetylcholine receptor Cloning of the α‐subunit cDNAFEBS Letters, 1988